Volume 1, Issue 2 (10-2024)                   IJHMD 2024, 1(2): 24-28 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ghojoghdordi M, Charkazi A. Barriers to receiving the booster dose of the COVID-19 vaccine among Turkmen people: A Content Analysis Study. IJHMD 2024; 1 (2) :24-28
URL: http://jhd.goums.ac.ir/article-1-33-en.html
1- East Health Research Center, Gonbad-e-Kavous Health Center, Golestan University of Medical Sciences, Gonbad-e-Kavous, Iran
2- Department of Public Health, School of Health, Golestan University of Medical Sciences, Gorgan, Iran , rcharkazi@yahoo.com
Abstract:   (546 Views)
Background: Vaccine hesitancy is a significant global issue. This study aims to explore the barriers that prevent Turkmen people from receiving their third or subsequent doses of the COVID-19 vaccine.
Methods: In this qualitative content analysis study, 35 Turkmen residents of Gonbad-e-Kavous, located in northern Iran, participated in semi-structured phone interviews. These interviews took place in August and September 2022 and focused on individuals who had not received their third or subsequent doses of the COVID-19 vaccine.
Results: The analysis identified five key factors that hindered individuals from receiving their COVID-19 vaccine booster shots: 1. perceived risk, 2. inaccurate rumors and beliefs, 3. negative experiences with the COVID-19 vaccine, 4. concerns about vaccine effectiveness, and 5. personal freedom considerations.
Conclusion: To enhance public acceptance of booster vaccines, healthcare policymakers must take action to build public trust in vaccines and offer documented, scientific responses to address inaccurate rumors and beliefs.

 
Full-Text [PDF 478 kb]   (170 Downloads) |   |   Full-Text (HTML)  (114 Views)  
Type of Study: Original Article | Subject: Clinical
Received: 2024/02/7 | Accepted: 2024/10/22 | Published: 2024/12/25

References
1. COVID-19 and Vaccination Against It in Iran. Ministry of Health and Medical Education. 2022. [View at Publisher]
2. Loubet P, Laureillard D, Martin A, Larcher R, Sotto A. Why promoting a COVID-19 vaccine booster dose? Anaesth Crit Care Pain Med. 2021;40(6):100967. [View at Publisher] [DOI] [PMID] [Google Scholar]
3. Andrews N, Stowe J, Kirsebom F, Toffa S, Rickeard T, Gallagher E, et al. Covid-19 vaccine effectiveness against the Omicron (B. 1.1. 529) variant. N Engl J Med. 2022;386(16):1532-46. [View at Publisher] [DOI] [PMID] [Google Scholar]
4. Moreira Jr ED, Kitchin N, Xu X, Dychter SS, Lockhart S, Gurtman A, et al. Safety and efficacy of a third dose of BNT162b2 COVID-19 vaccine. N Engl J Med. 2022;386(20):1910-21. [View at Publisher] [DOI] [PMID] [Google Scholar]
5. Burki T. Booster shots for COVID-19-the debate continues. Lancet Infect Dis. 2021;21(10):1359-60. [View at Publisher] [DOI] [PMID] [Google Scholar]
6. MacDonald NE. SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161-4. [View at Publisher] [DOI] [PMID] [Google Scholar]
7. Karafillakis E, Larson HJ, ADVANCE consortium. The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations. Vaccine. 2017;35(37):4840-50. [View at Publisher] [DOI] [PMID] [Google Scholar]
8. Cobos Muñoz D, Monzón Llamas L, Bosch-Capblanch X. Exposing concerns about vaccination in low-and middle-income countries: a systematic review. Int J Public Health. 2015;60(7):767-80. [View at Publisher] [DOI] [PMID] [Google Scholar]
9. European Parliament. European Parliament Resolution of 19 April 2018 on Vaccine Hesitancy and Drop in Vaccination Rates in Europe (2017/2951 RSP). 2018. [View at Publisher]
10. WHO. World Health Organization Ten threats to global health in 2019. [View at Publisher]
11. Rzymski P, Poniedziałek B, Fal A. Willingness to receive the booster COVID-19 vaccine dose in Poland. Vaccines. 2021;9(11):1286. [View at Publisher] [DOI] [PMID] [Google Scholar]
12. Yadete T, Batra K, Netski DM, Antonio S, Patros MJ, Bester JC. Assessing acceptability of COVID-19 vaccine booster dose among adult Americans: A cross-sectional study. Vaccines. 2021;9(12):1424. [View at Publisher] [DOI] [PMID] [Google Scholar]
13. Khankeh HR, Farrokhi M, Khanjani MS, Momtaz YA, Forouzan AS, Norouzi M, et al. The Barriers, Challenges, and Strategies of COVID-19 (SARS-CoV-2) Vaccine Acceptance: A Concurrent Mixed-Method Study in Tehran City, Iran. Vaccines. 2021;9(11):1248. [View at Publisher] [DOI] [PMID] [Google Scholar]
14. Lebni JY, Irandoost SF, Sedighi S, Ahmadi S, Hosseini R. Identifying the determinants of non-injection of covid-19 vaccine: A qualitative study in Urmia, Iran. Front Public Health. 2022;10:927400. [View at Publisher] [DOI] [PMID] [Google Scholar]
15. Glanz K, Rimer BK, Viswanath K. Health behavior and health education: theory, research, and practice. USA:John Wiley & Sons;2008. [View at Publisher] [Google Scholar]
16. Dennis A, Robin C, Jones LF, Carter H. Exploring vaccine hesitancy in care home employees in North West England: a qualitative study. BMJ Open. 2022;12(5):e055239. [View at Publisher] [DOI] [PMID] [Google Scholar]
17. Wang J, Lu X, Lai X, Lyu Y, Zhang H, Fenghuang Y, et al. The changing acceptance of COVID-19 vaccination in different epidemic phases in China: a longitudinal study. Vaccines. 2021;9(3):191. [View at Publisher] [DOI] [PMID] [Google Scholar]
18. Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, et al. Acceptance of a COVID-19 vaccine in Southeast Asia: a cross-sectional study in Indonesia. Front Public Health. 2020;8:381. [View at Publisher] [DOI] [PMID] [Google Scholar]
19. Montagni I, Ouazzani-Touhami K, Mebarki A, Texier N, Schück S, Tzourio C, et al. Acceptance of a Covid-19 vaccine is associated with ability to detect fake news and health literacy. J Public Health. 2021;43(4):695-702. [View at Publisher] [DOI] [PMID] [Google Scholar]
20. Ahmed W, Vidal-Alaball J, Downing J, Seguí FL. COVID-19 and the 5G conspiracy theory: social network analysis of Twitter data. J Med Internet Res. 2020;22(5):e19458. [View at Publisher] [DOI] [PMID] [Google Scholar]
21. Walter N, Brooks JJ, Saucier CJ, Suresh S. Evaluating the impact of attempts to correct health misinformation on social media: A meta-analysis. Health Commun. 2021;36(13):1776-84. [View at Publisher] [DOI] [PMID] [Google Scholar]
22. Siebenhaar KU, Köther AK, Alpers GW. Dealing with the COVID-19 infodemic: Distress by information, information avoidance, and compliance with preventive measures. Front Psychol. 2020;11:567905. [View at Publisher] [DOI] [PMID] [Google Scholar]
23. WHO. Infodemic management: an overview of infodemic management during COVID-19, January 2020-May 2021. 2021. [View at Publisher] [Google Scholar]
24. Lyu H, Zheng Z, Luo J. Both rates of fake news and fact-based news on twitter negatively Correlate with the state-level COVID-19 vaccine uptake. arXiv preprint [PPR: PPR362191]:2021. [View at Publisher] [Google Scholar]
25. Islam MS, Kamal A-HM, Kabir A, Southern DL, Khan SH, Hasan SM, et al. COVID-19 vaccine rumors and conspiracy theories: The need for cognitive inoculation against misinformation to improve vaccine adherence. PLoS One. 2021;16(5):e0251605. [View at Publisher] [DOI] [PMID] [Google Scholar]
26. Jemielniak D, Krempovych Y. An analysis of AstraZeneca COVID-19 vaccine misinformation and fear mongering on Twitter. Public Health. 2021;200:4-6. [View at Publisher] [DOI] [PMID] [Google Scholar]
27. Cahapay MB. To get or not to get: Examining the intentions of Philippine teachers to vaccinate against COVID-19. J Hum Behav Soc. 2022;32(3):325-35. [View at Publisher] [DOI] [Google Scholar]
28. van Summeren J, Meijer A, Aspelund G, Casalegno JS, Erna G, Hoang U, et al. Low levels of respiratory syncytial virus activity in Europe during the 2020/21 season: what can we expect in the coming summer and autumn/winter? Euro Surveill. 2021;26(29):2100639. [View at Publisher] [DOI] [PMID] [Google Scholar]
29. Lockyer B, Islam S, Rahman A, Dickerson J, Pickett K, Sheldon T, et al. Understanding COVID-19 misinformation and vaccine hesitancy in context: Findings from a qualitative study involving citizens in Bradford, UK. Health Expect. 2021;24(4):1158-67. [View at Publisher] [DOI] [PMID] [Google Scholar]
30. Woodhead C, Onwumere J, Rhead R, Bora-White M, Chui Z, Clifford N, et al. Race, ethnicity and COVID-19 vaccination: a qualitative study of UK healthcare staff. Ethn Health. 2022;27(7):1555-74. [View at Publisher] [DOI] [PMID] [Google Scholar]
31. Kumari A, Ranjan P, Chopra S, Kaur D, Kaur T, Kalanidhi KB, et al. What Indians Think of the COVID-19 vaccine: A qualitative study comprising focus group discussions and thematic analysis. Diabetes Metab Syndr. 2021;15(3):679-82. [View at Publisher] [DOI] [PMID] [Google Scholar]
32. Duong MC, Nguyen HT, Duong M. Evaluating COVID-19 vaccine hesitancy: A qualitative study from Vietnam. Diabetes Metab Syndr. 2022;16(1):102363. [View at Publisher] [DOI] [PMID] [Google Scholar]
33. Wang J, Ji Q, Dong S, Zhao S, Li X, Zhu Q, et al. Factors Influencing Vaccine Hesitancy in China: A Qualitative Study. Vaccines. 2021;9(11):1291. [View at Publisher] [DOI] [PMID] [Google Scholar]
34. Küçükali H, Ataç Ö, Palteki AS, Tokaç AZ, Hayran O. Vaccine hesitancy and anti-vaccination attitudes during the start of COVID-19 vaccination program: a content analysis on twitter data. Vaccines. 2022;10(2):161. [View at Publisher] [DOI] [PMID] [Google Scholar]
35. Siu JY-m, Cao Y, Shum DH. Perceptions of and hesitancy toward COVID-19 vaccination in older Chinese adults in Hong Kong: A qualitative study. BMC Geriatr. 2022;22(1):288. [View at Publisher] [DOI] [PMID] [Google Scholar]
36. Torabi M, Sotudeh H. The Role of Risk Perception and Ability to Detect Fake News in Acceptance of COVID-19 Vaccine among Students of Shiraz University, Iran. Health Inf Manag. 2022;18(6):265-71. [View at Publisher] [DOI] [Google Scholar]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | International Journal Of Health Management And Development

Designed & Developed by : Yektaweb